Drug intelligence / Profile preview

NanoAgCide

Development stage
Unknown
Lead developer
WeInnovate Biosolutions
Modality
Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

NanoAgCide is a patented antimicrobial technology developed by WeInnovate Biosolutions, an Indian startup. It consists of a colloidal silver nanoparticle solution designed as a broad-spectrum antimicrobial additive for medical devices and environmental sanitization. The technology utilizes silver nanoparticles that exert antimicrobial activity by interacting with viral surface glycoproteins to block entry and by interfering with viral replication processes, such as the synthesis of negative-strand RNA and viral budding. NanoAgCide is primarily used for infection prevention and control, particularly to reduce hospital-acquired infections (HAIs). It is incorporated into medical devices like the SilvoGuard Foley Catheter and is used in non-alcoholic, aqueous-based hand sanitizers and surface disinfectants. The technology has received British Pharmacopeia approval and is supported by the Indian Department of Science and Technology (DST) and Department of Biotechnology (DBT).

Brand names
NanoAgCide
Other names
colloidal silver nanoparticle solutionsilver nanoform
02

Targets

vRNA (Coronavirus viral RNA)

Beyond the preview

Go deeper on NanoAgCide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoAgCide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call